medigraphic.com
ISSN 1561-302X (Print)

2019, Number 3

<< Back Next >>

Rev cubana med 2019; 58 (3)

Glomerular filtration and cardiovascular disease in hypertensive patients

Tasis HM, Talavera HW, Rodríguez DAM

Language: Spanish
References: 30
Page: 1-15
PDF size: 344.79 Kb.


ABSTRACT

Introduction: Chronic kidney disease expressed by decreased glomerular filtration rate is associated with high risk of cardiovascular disease and great progression of kidney damage. This filtration is highly recommended as an available and inexpensive method to assess cardiovascular risk in hypertensive patients.
Objective: To assess kidney damage and cardiovascular disease in hypertensive patients at Managua Polyclinic.
Method: This research included 1037 hypertensive patients. Glomerular filtration was calculated according to the Modification Diet Renal Disease Study. Demographic variables, vascular risk factors, and the presence of cardiovascular disease were studied. The decreased glomerular filtration was defined for <60 thousand/min/1.73m2.
Results: 28.5% of the studied patients showed decreased glomerular filtration, higher prevalence of cardiovascular disease than those without kidney damage (53.4% vs. 33.9%; OR 2.19 95% CI 1.51-2, 82; p <0.001).
Conclusions: This study showed that chronic kidney disease is associated with high prevalence of cardiovascular disease, which establishes higher cardiovascular risk factor.


REFERENCES

  1. Pérez Caballero MD, Cordies Jackson L, Valdés Armenteros R, Tasis Hernández M. Bajo peso al nacer y el desarrollo de hipertensión arterial en adolescentes y jóvenes. Rev Cub Med. 2004;36(3):24-6.

  2. KDIGO. Definition and classification of CKD. Kidney International Supplements. 2013;3:19-62.

  3. Rodrigo Orozco B. Enfermedad cardiovascular en la enfermedad renal crónica. Med Clin Condes. 2015;26(2)142-55.

  4. Galcerán JM. Riesgo por enfermedad renal crónica: la epidemia revisada. Hipertens riesg vasc. 2010;27(5):183-86.

  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Join National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Seventh Report of the Join National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-7). JAMA. 2003;289:2560-72.

  6. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.

  7. Subiza AK, Odriozola M, Ríos P, Lamadrid V, Mazzuchi N, Gadola L. Riesgo cardiovascular en la enfermedad renal crónica. Rev Urug Cardiol. 2016[acceso: 21/02/2019];31(2):5-5. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688- 04202016000200005&lng=es

  8. Chowdhury Turin T, James MT, Jun M, Tonelli M, Coresh J, Manns BJ, et al. Short- Term Change in eGFR and Risk of Cardiovascular Events. J Am Heart Assoc. 2014;3:e000997. http://doi.org/10.1161/JAHA.114.000997

  9. Chen Q, Zhang Y, Ding D, Xia M, Li D, Yang Y, et al. Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease. PLoSONE. 2016;11(8):e0161599. http://doi.org/10.1371/journal.pone.0161599

  10. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonso Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. Ministerio de Salud Pública de Cuba. Rev Cub Med. 2017[acceso: 12/11/2018];56sup(4). Disponible en: http://scielo.sld.cu/scielo.php

  11. Herrero P, Marín R, Fernández Vega F, Gorostidi M, Riesgo A, Vázquez J, et al. Función renal y riesgo cardiovascular en pacientes con hipertensión arterial esencial. Estudio FRESHA. Nefrología. 2006;26(3):330-38.

  12. Castellanos Castillo Y, Fong Estrada JA, Vázquez Trigo JM, Oliva Fong J. Marcadores de daño renal en pacientes con factores de riesgo de enfermedad renal crónica. Medisan. 2018;22(2):142-44.

  13. Acuña L, Sánchez P, Soler LA, Alvis LF. Enfermedad renal en Colombia: prioridad para la gestión de riesgo. Rev Panam Salud Pública. 2016;40(1)232-34.

  14. Sánchez Lorenzo I, Leyva Feria Z, Sánchez Albor N. Daño renal en pacientes hipertensos atendidos en el hospital provincial de Las Tunas. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2016[acceso: 12/11/2018];41(12). Disponible en: http://www.revzoilomarinello.sld.cu/index.php/zmv/article/view/1004

  15. Anavekar NS, McMurray JJ, Velázquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-95.

  16. Ronald MA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: HOORN Study: Kidney Int. 2002;62:1402-7.

  17. Cedeño Mora S, Goicoechea M, Torres E, Verdalles U, Pérez de José A, Verde E, et al. Cardiovascular risk prediction in chronic kidney disease patients. Nefrología. 2017; 37:293- 300. http://dx.doi.org/10.1016/j.nefro.2016.10.002

  18. Wang A, Chen G, Cao Y, Liu X, Su Z, Yanxia L, et al. Estimated glomerular filtration rate, proteinuria, and risk of cardiovascular diseases and all-cause mortality in diabetic population: a community-based cohort study. Scientific Reports. 2017;7:17948. http://doi.org/10.1038/s41598-017-17965-z

  19. León Álvarez JL, García Sánchez N, Gutiérrez Rojas A, Pérez Caballero MD. Biomarcadores de daño renal en la hipertensión arterial esencial. Rev cubana med. 2016[acceso: 21/02/2019];55(4):297-310. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232016000400004&lng=es

  20. Hailpern SM, Cohen HW, Alderman MH. Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens. 2005;23:1809-16.

  21. Yuan J, Zou X, Han S. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2017;18(23). https://doi.org/10.1186/s12882-017- 0441-9

  22. Matsushita K, Ballew SH, Coresh J. Cardiovascular risk prediction in people with chronic kidney disease. Curr Opin Nephrol Hypertens. 2016;25(6):518-23. https://doi.org/10.1097/MNH.0000000000000265

  23. Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Chronic kidney disease in primary care: outcomes after five years in a prospective cohort study. PLoS Med. 2016;13(9):e10021-e10028. https://doi.org/10.1371/journal.pmed.1002128

  24. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease MDRD and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763-73.

  25. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46:233-41.

  26. López Labrada R, Casado Méndez PR, Ricardo Zamora Y, Del Castillo Remón IL. Eficacia de las fórmulas MDRD-abreviada y Cockcroft-Gault para la detección de insuficiencia renal crónica en la atención primaria. Medisan. 2014;18(2):183.

  27. Martínez Pérez D, de Alejo Rodríguez L, Moré Chang C, Rodríguez Viera R, Dupuy Núñez J. Estudios de laboratorio clínico para la detección de la enfermedad renal crónica en grupos poblacionales de riesgo. Medisan. 2016[acceso: 12/11/2018];20(1):50-59. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016000100008

  28. Gentille Lorente DI, Salvadó Usach T. Insuficiencia renal en pacientes cardiológicos: buscar para encontrar. Rev Med Chile. 2015[acceso: 12/11/2018];143(9):1105-13. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034- 98872015000900002&lng=es.http://dx.doi.org/10.4067/S0034-8872015000900002

  29. Martínez Pérez D, Pérez de Alejo Rodríguez L, Moré Chang CX, Rodríguez Viera R, Dupuy Núñez JC. Estudios de laboratorio clínico para la detección de la enfermedad renal crónica en grupos poblacionales de riesgo. Medisan. 2016[acceso: 12/11/2018];20(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192016000100008&lng=es

  30. Regueira Betancourt SM, Díaz Pérez MD, Jiménez Batioja GG, Cajape León LG. Morbilidad oculta de la enfermedad renal crónica en un consultorio médico de la familia. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2016[acceso: 12/11/2018];41(7). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/778




2020     |     www.medigraphic.com